These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 17333810

  • 1. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial.
    Iqbal J, Bukhari I, Jamshid M, Bashir S, Masoom Yasinzai M, Anwar M.
    East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810
    [Abstract] [Full Text] [Related]

  • 2. Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.
    el-On J, Sneier R, Elias E.
    Isr J Med Sci; 1992 Dec; 28(12):847-51. PubMed ID: 1286954
    [Abstract] [Full Text] [Related]

  • 3. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
    Coelho AC, Oliveira JC, Espada CR, Reimão JQ, Trinconi CT, Uliana SR.
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
    [Abstract] [Full Text] [Related]

  • 4. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
    Calvopina M, Gomez EA, Sindermann H, Cooper PJ, Hashiguchi Y.
    Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
    [Abstract] [Full Text] [Related]

  • 5. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
    Croft SL, Engel J.
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
    [Abstract] [Full Text] [Related]

  • 6. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of a married couple for American leishmaniasis with miltefosine.
    Wöhrl S, Schnedl J, Auer H, Walochnik J, Stingl G, Geusau A.
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):258-9. PubMed ID: 18211436
    [No Abstract] [Full Text] [Related]

  • 8. Miltefosine for new world cutaneous leishmaniasis.
    Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H.
    Clin Infect Dis; 2004 May 01; 38(9):1266-72. PubMed ID: 15127339
    [Abstract] [Full Text] [Related]

  • 9. Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report.
    Zerpa O, Blanco B, Kannee C, Ulrich M, Sindermann H, Engel J, Convit J.
    Int J Dermatol; 2006 Jun 01; 45(6):751-3. PubMed ID: 16796642
    [Abstract] [Full Text] [Related]

  • 10. [Leishmaniasis--oral treatment with hexadecylphosphocholine].
    Bommer W, Eibl HJ, Engel KR, Kuhlencord A, Sindermann H, Sundar S, Zappel H.
    Wien Klin Wochenschr; 2004 Jun 01; 116 Suppl 4():24-9. PubMed ID: 15683039
    [Abstract] [Full Text] [Related]

  • 11. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec 01; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J, Halevy S, Grunwald MH, Weinrauch L.
    J Am Acad Dermatol; 1992 Aug 01; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [Abstract] [Full Text] [Related]

  • 15. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses.
    Zerpa O, Ulrich M, Blanco B, Polegre M, Avila A, Matos N, Mendoza I, Pratlong F, Ravel C, Convit J.
    Br J Dermatol; 2007 Jun 01; 156(6):1328-35. PubMed ID: 17441955
    [Abstract] [Full Text] [Related]

  • 16. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
    el-On J, Sulitzeanu A, Schnur LF.
    Ann Trop Med Parasitol; 1991 Jun 01; 85(3):323-8. PubMed ID: 1746981
    [Abstract] [Full Text] [Related]

  • 17. First case of typical Old World cutaneous leishmaniasis treated with miltefosine.
    Stojkovic M, Junghanss T, Krause E, Davidson RN.
    Int J Dermatol; 2007 Apr 01; 46(4):385-7. PubMed ID: 17442078
    [Abstract] [Full Text] [Related]

  • 18. In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up.
    Coelho AC, Trinconi CT, Costa CH, Uliana SR.
    PLoS Negl Trop Dis; 2016 Jul 01; 10(7):e0004720. PubMed ID: 27416021
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.